Health
TGA investigates Guillain-Barre Syndrome diagnoses after AstraZeneca – The Australian
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians…
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians after they had the AstraZeneca vaccine.
“A possible link between Guillain-Barre Syndrome (GBS) and the AstraZeneca COVID-19 vaccine remains under investigation in Australia and internationally,” the TGA said.
“As of 19 May 2021, we have received eight reports of GBS in patients vaccinated with the AstraZeneca COVID-19 vaccine.
“The TGA continues…
-
General24 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News24 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business24 hours agoLessons from Warren Buffett’s ‘acts of omission’